These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 15583737

  • 1. In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profile.
    Gerotziafas GT, Chakroun T, Samama MM, Elalamy I.
    Thromb Haemost; 2004 Dec; 92(6):1296-302. PubMed ID: 15583737
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma.
    Gerotziafas GT, Depasse F, Chakroun T, Van Dreden P, Samama MM, Elalamy I.
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):149-56. PubMed ID: 15091002
    [Abstract] [Full Text] [Related]

  • 3. Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a.
    Graff J, Picard-Willems B, Harder S.
    Int J Clin Pharmacol Ther; 2007 Apr; 45(4):237-43. PubMed ID: 17474542
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation.
    Young G, Yonekawa KE, Nakagawa PA, Blain RC, Lovejoy AE, Nugent DJ.
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):97-103. PubMed ID: 17287624
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation.
    Linkins LA, Julian JA, Rischke J, Hirsh J, Weitz JI.
    Thromb Res; 2002 Sep 01; 107(5):241-4. PubMed ID: 12479885
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial.
    Anderson JA, Hirsh J, Yusuf S, Johnston M, Afzal R, Mehta SR, Fox KA, Budaj A, Eikelboom JW.
    J Thromb Haemost; 2010 Feb 01; 8(2):243-9. PubMed ID: 19943881
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential coagulation inhibitory effect of fondaparinux, enoxaparin and unfractionated heparin in cell models of thrombin generation.
    Ben-Hadj-Khalifa S, Hézard N, Almawi WY, Remy MG, Florent B, Mahjoub T, Nguyen P.
    Blood Coagul Fibrinolysis; 2011 Jul 01; 22(5):369-73. PubMed ID: 21577096
    [Abstract] [Full Text] [Related]

  • 10. Impact of antithrombin deficiency on efficacy of edoxaban and antithrombin-dependent anticoagulants, fondaparinux, enoxaparin, and heparin.
    Fukuda T, Kamisato C, Honda Y, Matsushita T, Kojima T, Furugohri T, Morishima Y, Shibano T.
    Thromb Res; 2013 Jun 01; 131(6):540-6. PubMed ID: 23673387
    [Abstract] [Full Text] [Related]

  • 11. Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood.
    Gerotziafas GT, Depasse F, Chakroun T, Samama MM, Elalamy I.
    Thromb Haemost; 2004 Mar 01; 91(3):531-7. PubMed ID: 14983229
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo.
    Yau JW, Stafford AR, Liao P, Fredenburgh JC, Roberts R, Weitz JI.
    Blood; 2011 Dec 15; 118(25):6667-74. PubMed ID: 21937693
    [Abstract] [Full Text] [Related]

  • 13. Thromboelastogram-guided enoxaparin dosing does not confer protection from deep venous thrombosis: a randomized controlled pilot trial.
    Louis SG, Van PY, Riha GM, Barton JS, Kunio NR, Underwood SJ, Differding JA, Rick E, Ginzburg E, Schreiber MA.
    J Trauma Acute Care Surg; 2014 Apr 15; 76(4):937-42; discussion 942-3. PubMed ID: 24662855
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.